Status:
UNKNOWN
NGS vs Culture Outcomes for Treatment of PJI
Lead Sponsor:
Center for Innovation and Research Organization
Conditions:
Prosthetic Joint Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This multicenter, randomized controlled trial will compare the use of NGS and traditional culture in directing antimicrobial treatment for patients with periprosthetic joint infection.
Eligibility Criteria
Inclusion
- Adults (age \> 18 years)
- Undergoing single stage revision or 1st stage resection arthroplasty/spacer placement for PJI (ICM-positive) of the hip or knee
- Written informed consent
Exclusion
- Ongoing participation in another clinical trial
- Megaprosthesis
Key Trial Info
Start Date :
September 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05247281
Start Date
September 21 2022
End Date
May 1 2025
Last Update
November 8 2023
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California
Los Angeles, California, United States, 90033
2
Cleveland Clinic Florida
Weston, Florida, United States, 33331
3
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03766
4
Columbia University
New York, New York, United States, 10032